Let’s start up with the current stock price of Immix Biopharma Inc. (IMMX), which is $2.28 to be very precise. The Stock rose vividly during the last session to $2.69 after opening rate of $2.51 while the lowest price it went was recorded $2.27 before closing at $2.43.
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Immix Biopharma Inc. shares are logging -73.73% during the 52-week period from high price, and 82.40% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $1.25 and $8.68.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 582097 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Immix Biopharma Inc. (IMMX) recorded performance in the market was -35.96%, having the revenues showcasing 2.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 31.62M, as it employees total of 2 workers.
Immix Biopharma Inc. (IMMX) in the eye of market guru’s
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 2.43, with a change in the price was noted -1.27. In a similar fashion, Immix Biopharma Inc. posted a movement of -35.77% for the period of last 100 days, recording 2,217,636 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for IMMX is recording 0.01 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Immix Biopharma Inc. (IMMX): Stocks Technical analysis and Trends
Raw Stochastic average of Immix Biopharma Inc. in the period of last 50 days is set at 46.82%. The result represents improvement in oppose to Raw Stochastic average for the period of the last 20 days, recording 30.54%. In the last 20 days, the company’s Stochastic %K was 36.47% and its Stochastic %D was recorded 42.29%.
If we look into the earlier routines of Immix Biopharma Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -35.96%. The shares increased approximately by -3.80% in the 7-day charts and went down by 39.88% in the period of the last 30 days. Common stock shares were driven by 2.70% during last recorded quarter.